Rate My Professor David King

David King's scholarly contributions include 75 works spanning 1999 to 2025, with 44 journal articles, 15 conference papers, 17 newspaper articles, and other outputs. His research addresses evidence-based medicine, clinical epidemiology, medical education, communication skills in general practice, depression, mental health, and topics such as acute upper respiratory tract infections, chronic cough, smoking cessation, and post-COVID mental health outcomes. Notable publications are the Cochrane systematic review "Saline nasal irrigation for acute upper respiratory tract infections" (2015), updates on "Homeopathic medicinal products for preventing and treating acute respiratory tract infections" (2018, 2022), "Cytisinicline for 6 or 12 wk increased smoking cessation rates after treatment and up to 24 wk" (Annals of Internal Medicine, 2025), "Patients surviving COVID-19 had increased risk for adverse mental health outcomes" (Annals of Internal Medicine, 2022), and the "Cough in Children and Adults: Diagnosis, Assessment and Management" position statement (Medical Journal of Australia, 2023). He has supervised PhD candidates on depression explanatory models in primary care, expectations of midlife intending mothers in assisted reproductive technology, and computer-tailored interventions for health behaviours. King received funding from the Medical Benefits Fund of Australia Limited for the Prudence factorial randomised trial on primary prevention of chronic degenerative diseases (2007-2009). He is a media commentator, authoring articles in The Conversation on sore throats, persistent coughs, nasal mucus colours, prolonged colds, and coronavirus self-treatment.